- Home
- Products
- Customized ADCs
- CD22
- Anti-CD22 (clone HB22.7)-saporin ADC
Anti-CD22 (clone HB22.7)-saporin ADC (CAT#: ADC-W-586)
This ADC product is comprised of an anti-CD22 monoclonal antibody (clone HB22.7) conjugated via a linker to saporin.
- Product Information
- ADC Target
- ADC Antibody
- ADC payload drug
- Antibody clone #
- HB227
- Name
- CD22
- Alternative Names
- CD22; CD22 molecule; SIGLEC2; SIGLEC-2; B-cell receptor CD22; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; B-lymphocyte cell adhesion molecule; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2;
- Target Entrez Gene ID
- 933
- Target UniProt ID
- P20273
- Overview
- CD22, or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins. It is found on the surface of mature B cells and to a lesser extent on some immature B cells. Generally speaking, CD22 is a regulatory molecule that prevents the overactivation of the immune system and the development of autoimmune diseases. CD22 is a sugar binding transmembrane protein, which specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. The presence of Ig domains makes CD22 a member of the immunoglobulin superfamily. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signaling. It is also involved in the B cell trafficking to Peyer's patches in mice.
- Overview
- Anti-CD22 Antibody, clone # HB227
- Clone #
- HB227
- Species Reactivity
- Human
- Name
- saporin
- Description
- Saporin is a plant toxin belonging to the ribosome-inactivating protein (RIP) family, a class of toxic enzymes that is widely distributed among plant genera whose activity is classically identified as rRNA N-glycosylase DNA.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-MUC1 (Sontuzumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-2490)
- Anti-TNFSF11 (Denosumab)-MC-MMAF ADC (CAT#: ADC-W-2236)
- Anti-HBV (Exbivirumab)-SPDB-DM4 ADC (CAT#: ADC-W-2073)
- Anti-SLC34A2 (Lifastuzumab)-VC-MMAE ADC (CAT#: ADC-W-499)
- Anti-NGcGM3 (Racotumomab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2267)
- Anti-EGFL7 (Parsatuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1033)
- Anti-PCSK9 (Ralpancizumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-2316)
- Anti-CD4 (Zanolimumab)-SPDB-DM4 ADC (CAT#: ADC-W-855)
- Anti-IFNAR (Anifrolumab)-SMCC-DM1 ADC (CAT#: ADC-W-2054)
- Anti-CD22 (clone 10F4)-SMCC-DM1 ADC (CAT#: ADC-W-189)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-586. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
CAT# | Product Name | Linker | Payload |
ADC-W-2536 | Anti-CD22 (Pinatuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
ADC-W-2526 | Anti-CD22 (Inotuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
ADC-W-2533 | Anti-CD22 (Pinatuzumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
ADC-W-2524 | Anti-CD22 (Inotuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
ADC-W-2532 | Anti-CD22 (Pinatuzumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.